Patel, V. M., Balakrishnan, K., Douglas, M., Tibbitts, T., Xu, E. Y., Kutok, J. L., . . . Gandhi, V. (2016). Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199). Leukemia.
Styl ChicagoPatel, Viralkumar M., et al. "Duvelisib Treatment Is Associated With Altered Expression of Apoptotic Regulators That Helps in Sensitization of Chronic Lymphocytic Leukemia Cells to Venetoclax (ABT-199)." Leukemia 2016.
Citace podle MLAPatel, Viralkumar M., et al. "Duvelisib Treatment Is Associated With Altered Expression of Apoptotic Regulators That Helps in Sensitization of Chronic Lymphocytic Leukemia Cells to Venetoclax (ABT-199)." Leukemia 2016.